FDA Issues Two Final Guidances: Use of EHRs, Electronic OTC Monograph Submissions

The FDA has finalized its guidance on the use of electronic health records (EHR) or medical claims data in clinical studies to support a regulatory decision for effectiveness or safety.
Source: Drug Industry Daily